| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Immune Globulin Therapy | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | External Infusion Pumps | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Pharmacogenomics Testing | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Billing and Coding: Molecular Pathology and Genetic Testing | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Belantamab mafodotin (Blenrep) | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Ustekinumab (Stelara) and Ustekinumab Biosimilars | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Denosumab (Prolia, Xgeva) and Denosumab Biosimilars | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Monoclonal Antibodies for the Treatment of Eosinophilic Conditions | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Treatment of Spinal Muscular Atrophy | 2026-07-01 |
| BCBS Highmark NY and West NY | Pharmacogenetic/Pharmacogenomic Testing | 2026-07-01 |